Determining how effectively a drug is being absorbed by the human body is a tricky business.
While age and weight can give doctors a good indication, a patients’ metabolism, the foods they eat and other drugs they might be taking can all have an effect on efficacy.
Looking to solve this problem, engineers from the University of California, Santa Barbara have developed an implantable device that provides real time feedback on how much medication is currently in a person’s bloodstream.
While still in the early stages of development, the researchers say the prototype device, called MEDIC (Microfluidic Electrochemical Detector for In vivo Concentrations), could revolutionise the way treatment is given and measured in the future.
Kevin Plaxco, a professor of biomolecular science and engineering, believes it could even be used to deliver drugs automatically, with dosages based on the feedback generated by the device.
An artificial pancreas, which monitors glucose levels in diabetics and uses this information to inject a controlled amount of insulin, is an example of one such system.
The MEDIC device consists of a microfluidic chamber lined with gold electrodes from which drug-recognising biomolecules – in this case artificial DNA strands called aptamers – extend.
When the target molecule comes in contact with an aptamer, the strand recognises it and wraps around the molecule, delivering electrons from its tip to the electrode at the aptamer’s base. The tiny jolt of current signals the presence of the molecule.
Because previous iterations of the device failed within half an hour – due to the components in whole blood clinging to the sensors – the researchers decided to introduce a second flow into the chamber.
This acted like a filter, separating the large blood components from the small drug molecules.
In tests, the researchers found they could easily and accurately measure the effectiveness of a particular drug in the bloodstream, even when a cocktail of drugs was administered.
The Latest on: Drug levels in the bloodstream
[google_news title=”” keyword=”Drug levels in the bloodstream” num_posts=”10″ blurb_length=”0″ show_thumb=”left”]
via Google News
The Latest on: Drug levels in the bloodstream
- 2 Idaho children show elevated blood lead levels after consuming recalled applesauceon November 30, 2023 at 10:08 am
Idaho health officials are urging anyone whose children consumed the product to have them tested for lead poisoning.
- ‘Ashamed’ mom almost dies after buying $190 counterfeit ‘skinny drug’ onlineon November 29, 2023 at 11:47 am
The shocking story comes after health authorities around the world warned of the rise in counterfeit Ozempic pens.
- Mother-of-two nearly died in front of daughter after 'skinny drug' jabon November 29, 2023 at 2:28 am
Doctors told mother-of-two Michelle Sword (pictured), 45, from Oxfordshire, she was very lucky to be alive after self-administering a 'dangerous' weight-loss pen she bought online for £150 in ...
- What happens during a typical three-drug lethal injectionon November 28, 2023 at 11:01 am
Here’s what happens in one state during a typical three-drug lethal injection, the most common method of enacting the death penalty where it is legal in the US.
- Lexaria's Technology Lowers Blood Glucose More Effectively than Rybelsus(R)-Branded GLP-1 drug Semaglutide Alone in Human Pilot Studyon November 28, 2023 at 6:09 am
DehydraTECHTM-powered semaglutide achieved these benefits in a human pilot study compared to Rybelsus®:Sustained lower levels of blood glucose from baseline including nearly 10x lower after 24 ...
- A Life-Extension Drug for Big Dogs Is Getting Closer to Realityon November 27, 2023 at 9:01 pm
The FDA has yet to approve any drugs for life extension. But biotech company Loyal is now a step closer to bringing one to market—for dogs.
- Cholesterol drugs could stop fatal heart rupture in menon November 27, 2023 at 5:15 pm
An AAA is a balloon-like swelling of the lower part of the aorta, the body's main artery that pumps blood from the heart to the rest of the body.
- GSK's blood cancer drug meets primary goal in late-stage trialon November 27, 2023 at 9:13 am
GSK said on Monday that its blood cancer drug Blenrep had reached a key goal in a late-stage trial, as the British drugmaker looks to bolster its oncology business after a series of setbacks.
- Lexaria's Technology Improves the Oral Performance of the Rybelsus(R)-Branded GLP-1 drug Semaglutide in Human Pilot Studyon November 27, 2023 at 6:05 am
DehydraTECHTM-powered semaglutide achieved these benefits in a human pilot study compared to Rybelsus®:Sustained higher levels of semaglutide in blood;Faster achievement of peak drug delivery; ...
- The uses and risks of statinson November 21, 2023 at 4:00 pm
Below, we describe the uses, risks, and possible benefits of these drugs. Doctors typically prescribe statins to lower blood cholesterol levels. These drugs block the action of a liver enzyme that ...
via Bing News